Action
Dabigatran is an anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications, for some of which it may replace warfarin as the preferred anticoagulant. It is orally administered as the prodrug dabigatran etexilate.

Status

Trial(s)
  = Ongoing
  = Completed

RE-LY

Randomized Evaluation of Long Term Anticoagulant Therapy With Dabigatran Etexilate

UID: 344